Search for: "House v. Mayo"
Results 61 - 80
of 104
Sorted by Relevance
|
Sort by Date
8 Aug 2012, 7:52 am
There was once a dustup over the “Blue Ribbon” device in the 1932 case of Richard Hellman, Inc. v. [read post]
16 May 2021, 6:25 pm
”In his book The House of the Pain of Others: Chronicl [read post]
5 Aug 2009, 5:35 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: America’s Affordable Health Choices Act : House Energy & Commerce Committee OKs 12-year data exclusivity for biotech drugs (Patent Baristas) (Patent Docs) (FDA Law Blog) (PatentlyBIOtech) (GenericsWeb) General Pharmaceutical patent settlements under fire on both sides of the Atlantic (GenericsWeb)… [read post]
28 Sep 2023, 7:33 am
” James V. [read post]
20 Jul 2015, 2:54 pm
" In reaching her decision, the judge cited last year's Supreme Court ruling in Alice Corp v CLS Bank stating that "while the very idea of allowing multiple-device playback may have been novel at the time of invention, the second step of the Alice/Mayo test requires more than a novel ideal - it requires a specific application of that idea, to ensure that all embodiments of the idea (even if novel) are not preempted. [read post]
31 Dec 2013, 7:44 pm
Mayo v. [read post]
11 Nov 2009, 4:02 am
(BiotechBlog) 'Most important' biodiversity access / benefit meeting (IP Watch) EU: Patentability of gene sequences and Directive 98/44 (JIPLP) EU: Generics producers: Criminal sanctions can stop counterfeit drugs (IP Watch) US: Mayo seeks Supreme Court review in Prometheus Labs case (Patent Docs) US: Follow-on biologics news briefs - No 9: Patient groups back Senate and House Committee FOB legislation; DelawareBio and BIO seek support of Delaware Delegation; CCPM asks… [read post]
29 Oct 2011, 11:59 am
Mayo v. [read post]
11 Nov 2009, 4:02 am
(BiotechBlog) 'Most important' biodiversity access / benefit meeting (IP Watch) EU: Patentability of gene sequences and Directive 98/44 (JIPLP) EU: Generics producers: Criminal sanctions can stop counterfeit drugs (IP Watch) US: Mayo seeks Supreme Court review in Prometheus Labs case (Patent Docs) US: Follow-on biologics news briefs - No 9: Patient groups back Senate and House Committee FOB legislation; DelawareBio and BIO seek support of Delaware Delegation; CCPM asks… [read post]
6 Jul 2011, 2:21 am
Pharmacia & Upjohn in liquidazione and Pfizer Italia s.r.l (Kluwer Patent Blog) US: IPO releases list of top 300 patent holders for 2010 (Patent Docs) US: Supreme Court to hear more patent cases in October 2011 term: Mayo v Prometheus; Kappos v Hyatt; Caraco v Novo Nordisk (Inventive Step) US: In pleading inequitable conduct, inventor’s citation to withheld reference does not establish knowledge of reference sufficient to satisfy FRCP 9(b): Fred… [read post]
20 Jul 2009, 2:00 am
(PatLit) United States US General House approves USPTO funding bill (Managing Intellectual Property) US measures to strengthen trade enforcement (Intellectual Property Watch) US Patents Peer-to-patent project set on hold. [read post]
19 Dec 2011, 6:35 am
American Medical News reports on the oral argument earlier this month in Mayo Collaborative Services v. [read post]
11 May 2013, 11:36 am
A political (or a religious) worldview places core commitments above empirical data, as was so clearly revealed in the case of The Vatican v. [read post]
22 Apr 2017, 1:00 am
Smith v. [read post]
4 Jun 2014, 7:41 pm
Co. v. [read post]
1 May 2020, 3:30 am
It comes from this 1985 case called Sabine Pilot Service, Inc. v. [read post]
21 Oct 2009, 6:13 am
– response to IAM article suggesting pharmaceutical companies will subsidise Rio 2016 (IP tango) EU: India, Brazil to file WTO complaint against the EU over ‘seizures’ of pharma drug consignments (Spicy IP) US: PhRMA supports follow-on biologics regulatory pathway providing 12 years of data exclusivity (Patent Docs) US: Senators Orrin Hatch, Barbara Mikulski, Michael Enzi and Kay Hagan write in support of 12-year data exclusivity period (Patent Docs) US: New England… [read post]
21 Oct 2009, 5:13 am
- response to IAM article suggesting pharmaceutical companies will subsidise Rio 2016 (IP tango) EU: India, Brazil to file WTO complaint against the EU over 'seizures' of pharma drug consignments (Spicy IP) US: PhRMA supports follow-on biologics regulatory pathway providing 12 years of data exclusivity (Patent Docs) US: Senators Orrin Hatch, Barbara Mikulski, Michael Enzi and Kay Hagan write in support of 12-year data exclusivity period (Patent Docs) US: New England Journal of Medicine say… [read post]
21 Oct 2009, 5:13 am
- response to IAM article suggesting pharmaceutical companies will subsidise Rio 2016 (IP tango) EU: India, Brazil to file WTO complaint against the EU over 'seizures' of pharma drug consignments (Spicy IP) US: PhRMA supports follow-on biologics regulatory pathway providing 12 years of data exclusivity (Patent Docs) US: Senators Orrin Hatch, Barbara Mikulski, Michael Enzi and Kay Hagan write in support of 12-year data exclusivity period (Patent Docs) US: New England Journal of Medicine say… [read post]
16 May 2016, 8:58 am
We also have Mayo v. [read post]
